Veradigm: A Relisting Special Situation With Strategic Optionality

Core Insights - Veradigm, previously known as Allscripts, has a long history in healthcare IT and has experienced multiple market cycles [1] - The company underwent rebranding in 2022 after selling its previous business [1] Company Overview - Veradigm is focused on identifying growth opportunities in the stock market while maintaining a reasonable price and strong economic moats [1] - The company emphasizes high-quality analysis, including valuations, key business drivers, risk/reward assessments, and various future scenarios [1]